Stock Events

Stock Events

Aethlon Medical 

$2.99
96
+$0.16+5.65% 12:31 Today

Statistics

Day High
2.87
Day Low
2.86
52W High
109.5
52W Low
2.65
Volume
1,261
Avg. Volume
-
Mkt Cap
1.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
-8.61
-6.09
-3.56
-1.04
Expected EPS
-3.85
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-7.15MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AEMD. It's not an investment recommendation.
Amazon
12
AMZN
NVIDIA
12
NVDA
Apple
11
AAPL
Realty Income
11
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cytodyn
CYDY
Mkt Cap315.04M
CytoDyn Inc. focuses on innovative treatments for HIV and cancer, similar to Aethlon's focus on life-threatening diseases, making them direct competitors in the biotech space.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops drugs for life-threatening illnesses, including viral diseases, which competes with Aethlon's Hemopurifier therapy.
Sorrento Therapeutics
SRNE
Mkt Cap385,896
Sorrento Therapeutics, Inc. works on developing therapies for cancer, autoimmune, and infectious diseases, directly competing with Aethlon's disease treatment technologies.
Novavax
NVAX
Mkt Cap1.33B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with Aethlon's focus on therapeutic devices for viral diseases.
Moderna
MRNA
Mkt Cap25.28B
Moderna, Inc. specializes in drug discovery and drug development based on messenger RNA, competing in the infectious disease space with Aethlon.
Inovio Pharmaceuticals
INO
Mkt Cap112.7M
Inovio Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of DNA-based immunotherapies, competing with Aethlon's therapeutic technologies.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics AG specializes in gene editing technologies, which could compete with Aethlon's therapeutic approaches in treating diseases at the genetic level.
Novartis
NVS
Mkt Cap286.78B
Novartis AG is a global healthcare company that researches, develops, manufactures, and markets healthcare products, competing across a broad range of therapeutic areas including those targeted by Aethlon.

About

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
Show more...
CEO
James Frakes
Employees
9
Country
United States
ISIN
US00808Y7031
WKN
000A42HQZ

Listings

MU
DE
EJU.MU
STU
DE
EJU.STU
STU
DE
EJUN.STU
BOATS
BOATS
AEMD.BOATS

0 Comments

Share your thoughts

FAQ

What is Aethlon Medical stock price today?▼
The current price of AEMD is $2.99 USD — it has increased by +5.65% in the past 24 hours. Watch Aethlon Medical stock price performance more closely on the chart.
What is Aethlon Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Aethlon Medical stocks are traded under the ticker AEMD.
Is Aethlon Medical stock price growing?▼
AEMD stock has fallen by -8.12% compared to the previous week, the month change is a -12.92% fall, over the last year Aethlon Medical has showed a -95.04% decrease.
What is Aethlon Medical market cap?▼
Today Aethlon Medical has the market capitalization of 1.49M
When is the next Aethlon Medical earnings date?▼
Aethlon Medical is going to release the next earnings report on November 18, 2026.
What were Aethlon Medical earnings last quarter?▼
AEMD earnings for the last quarter are -4.02 USD per share, whereas the estimation was -3.93 USD resulting in a -2.42% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aethlon Medical revenue for the last year?▼
Aethlon Medical revenue for the last year amounts to 0 USD.
What is Aethlon Medical net income for the last year?▼
AEMD net income for the last year is -7.15M USD.
How many employees does Aethlon Medical have?▼
As of August 17, 2026, the company has 9 employees.
In which sector is Aethlon Medical located?▼
Aethlon Medical operates in the Health & Wellness sector.
When did Aethlon Medical complete a stock split?▼
The last stock split for Aethlon Medical was on October 20, 2025 with a ratio of 1:10.
Where is Aethlon Medical headquartered?▼
Aethlon Medical is headquartered in SAN DIEGO, United States.